Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapy

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2041-1723
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapy ; volume:13 ; number:1 ; day:3 ; month:10 ; year:2022 ; pages:1-17 ; date:12.2022
Nature Communications ; 13, Heft 1 (3.10.2022), 1-17, 12.2022

Creator
Pavlidis, Polychronis
Tsakmaki, Anastasia
Pantazi, Eirini
Li, Katherine
Cozzetto, Domenico
Digby- Bell, Jonathan
Yang, Feifei
Lo, Jonathan W.
Alberts, Elena
Sa, Ana Caroline Costa
Niazi, Umar
Friedman, Joshua
Long, Anna K.
Ding, Yuchun
Carey, Christopher D.
Lamb, Christopher
Saqi, Mansoor
Madgwick, Matthew
Gul, Leila
Treveil, Agatha
Korcsmaros, Tamas
Macdonald, Thomas T.
Lord, Graham M.
Bewick, Gavin
Powell, Nick
Contributor
SpringerLink (Online service)

DOI
10.1038/s41467-022-33331-8
URN
urn:nbn:de:101:1-2022122121063718047196
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:38 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Pavlidis, Polychronis
  • Tsakmaki, Anastasia
  • Pantazi, Eirini
  • Li, Katherine
  • Cozzetto, Domenico
  • Digby- Bell, Jonathan
  • Yang, Feifei
  • Lo, Jonathan W.
  • Alberts, Elena
  • Sa, Ana Caroline Costa
  • Niazi, Umar
  • Friedman, Joshua
  • Long, Anna K.
  • Ding, Yuchun
  • Carey, Christopher D.
  • Lamb, Christopher
  • Saqi, Mansoor
  • Madgwick, Matthew
  • Gul, Leila
  • Treveil, Agatha
  • Korcsmaros, Tamas
  • Macdonald, Thomas T.
  • Lord, Graham M.
  • Bewick, Gavin
  • Powell, Nick
  • SpringerLink (Online service)

Other Objects (12)

Real-World Effectiveness and Risk Factors for Discontinuation of Ustekinumab in Ulcerative Colitis

Real-World Effectiveness and Risk Factors for Discontinuation of Ustekinumab in Ulcerative Colitis

Successful cyclosporin and ustekinumab combination therapy in a patient with severe steroid-refractory ulcerative colitis

Successful cyclosporin and ustekinumab combination therapy in a patient with severe steroid-refractory ulcerative colitis

Ulcerative colitis - Crohn's disease

Ulcerative colitis - Crohn's disease

Ulcerative Colitis: Shifting Sands

Ulcerative Colitis: Shifting Sands

Ustekinumab bei Colitis ulcerosa und Morbus Crohn : gute anti-entzündliche Wirkung von Ustekinumab in beiden Indikationen

Fallstudiensammlung

Ustekinumab bei Colitis ulcerosa und Morbus Crohn : gute anti-entzündliche Wirkung von Ustekinumab in beiden Indikationen

Biological characteristics of molecular subtypes of ulcerative colitis characterized by ferroptosis and neutrophil infiltration

Biological characteristics of molecular subtypes of ulcerative colitis characterized by ferroptosis and neutrophil infiltration

Appendiceal mucocele in ulcerative colitis

Appendiceal mucocele in ulcerative colitis

Specific immunotherapy ameliorates ulcerative colitis

Specific immunotherapy ameliorates ulcerative colitis

Real-World Data on Short-Term and Long-Term Treatment Results of Ustekinumab in Patients with Steroid-Resistant/Dependent Ulcerative Colitis

Real-World Data on Short-Term and Long-Term Treatment Results of Ustekinumab in Patients with Steroid-Resistant/Dependent Ulcerative Colitis

Listeria monocytogenes sepsis in ulcerative colitis

Listeria monocytogenes sepsis in ulcerative colitis

Immunophenotyping of patients with ulcerative colitis

Immunophenotyping of patients with ulcerative colitis

Ozanimod: A Review in Ulcerative Colitis

Ozanimod: A Review in Ulcerative Colitis

Related objects